Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis (Q73270536)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 April 1997

Language	Label	Description	Also known as
English	Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis	scientific article published on 01 April 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119961%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119961%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

based on heuristic

inferred from title

experimental autoimmune encephalomyelitis

0 references

author name string

D Lehmann

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119961%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D M Karussis

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119961%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Fluresco

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119961%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Mizrachi-Koll

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119961%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H Ovadia

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119961%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E Shezen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119961%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Kalland

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119961%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

O Abramsky

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119961%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 April 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119961%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Journal of Neuroimmunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119961%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

74

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119961%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119961%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

102-110

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119961%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Multiple sclerosis: immune mechanism and update on current therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Stimulation of NK cell, T cell, and monocyte functions by the novel immunomodulator Linomide after autologous bone marrow transplantation. A pilot study in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Paradoxical effects of LS-2616 (Linomide) treatment in the type II collagen arthritis model in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The quinoline-3-carboxamide linomide inhibits angiogenesis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunomodulation of experimental autoimmune myasthenia gravis with linomide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide: a double-blind, placebo-controlled pilot study with monthly magnetic resonance imaging evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of action of the new immunomodulator LS2616 on T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral administration of the oxidant-scavenger N-acetyl-L-cysteine inhibits acute experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Amelioration of intrathymic T cell development and peripheral T cell reactivities in autoimmune mice undergoing therapy with a novel immunomodulator

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the novel immunomodulator LS 2616 on the delayed-type hypersensitivity reaction to Bordetella pertussis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment of autoimmunity in MRL/1 mice with LS-2616, a new immunomodulator

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0165-5728(96)00211-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119961%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9119961%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73270536&oldid=2216605723"